tiprankstipranks
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market
MARKSANS
Marksans Pharma Limited
RESEARCH TOOLSreports
Want to see IN:MARKSANS full AI Analyst Report?

Marksans Pharma Limited (MARKSANS) Ratios

6 Followers

Marksans Pharma Limited Ratios

IN:MARKSANS's free cash flow for Q2 2026 was ₹0.57. For the 2026 fiscal year, IN:MARKSANS's free cash flow was decreased by ₹ and operating cash flow was ₹0.19. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 5.17 5.17 4.62 4.78 4.91
Quick Ratio
 3.32 3.32 2.85 3.19 3.49
Cash Ratio
 1.88 1.88 1.04 1.03 1.12
Solvency Ratio
 0.64 0.64 0.62 0.65 0.75
Operating Cash Flow Ratio
 0.14 0.91 0.43 0.59 0.70
Short-Term Operating Cash Flow Coverage
 1.03 6.57 8.95 7.92 5.71
Net Current Asset Value
₹ 19.15B₹ 19.15B₹ 14.54B₹ 12.67B₹ 12.50B
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.09 0.10 0.09 0.06
Debt-to-Equity Ratio
 0.11 0.11 0.13 0.12 0.07
Debt-to-Capital Ratio
 0.10 0.10 0.12 0.11 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.28 1.28 1.31 1.30 1.26
Debt Service Coverage Ratio
 5.21 4.75 11.72 9.94 6.43
Interest Coverage Ratio
 20.81 20.92 96.81 34.59 32.85
Debt to Market Cap
 <0.01 0.01 <0.01 <0.01 0.01
Interest Debt Per Share
 8.11 8.11 7.36 5.63 3.18
Net Debt to EBITDA
 -1.00 -1.07 -0.33 -0.31 -0.65
Profitability Margins
Gross Profit Margin
47.66%39.20%56.39%50.67%50.25%
EBIT Margin
18.62%17.10%16.98%19.97%18.72%
EBITDA Margin
21.96%20.45%20.16%23.38%21.52%
Operating Profit Margin
17.02%17.10%43.04%17.80%16.19%
Pretax Profit Margin
19.00%19.00%19.21%19.45%18.23%
Net Profit Margin
14.16%14.16%14.51%14.41%14.38%
Continuous Operations Profit Margin
14.23%14.23%14.59%14.46%14.33%
Net Income Per EBT
74.55%74.55%75.52%74.07%78.87%
EBT Per EBIT
111.63%111.05%44.65%109.30%112.62%
Return on Assets (ROA)
10.82%10.82%11.75%11.70%12.16%
Return on Equity (ROE)
15.67%13.82%15.43%15.19%15.26%
Return on Capital Employed (ROCE)
15.06%15.14%40.86%16.91%16.21%
Return on Invested Capital (ROIC)
11.04%11.10%30.38%12.29%12.36%
Return on Tangible Assets
11.30%11.30%12.17%12.17%12.80%
Earnings Yield
3.75%5.88%3.78%4.38%9.11%
Efficiency Ratios
Receivables Turnover
 4.58 4.58 4.84 4.74 4.41
Payables Turnover
 4.58 5.33 3.74 4.00 4.00
Inventory Turnover
 1.59 1.85 1.35 1.74 1.90
Fixed Asset Turnover
 3.14 3.14 2.93 3.14 4.79
Asset Turnover
 0.76 0.76 0.81 0.81 0.85
Working Capital Turnover Ratio
 1.44 1.50 1.64 1.55 1.70
Cash Conversion Cycle
 229.87 208.98 247.72 195.76 183.40
Days of Sales Outstanding
 79.73 79.73 75.45 76.93 82.73
Days of Inventory Outstanding
 229.75 197.79 269.83 210.00 192.03
Days of Payables Outstanding
 79.61 68.54 97.56 91.17 91.35
Operating Cycle
 309.48 277.52 345.28 286.93 274.76
Cash Flow Ratios
Operating Cash Flow Per Share
 1.66 10.63 4.56 5.08 5.72
Free Cash Flow Per Share
 0.04 7.75 0.74 0.48 4.42
CapEx Per Share
 1.62 2.88 3.82 4.61 1.29
Free Cash Flow to Operating Cash Flow
 0.03 0.73 0.16 0.09 0.77
Dividend Paid and CapEx Coverage Ratio
 0.69 2.89 1.03 1.00 3.72
Capital Expenditure Coverage Ratio
 1.03 3.69 1.20 1.10 4.43
Operating Cash Flow Coverage Ratio
 0.22 1.40 0.64 0.94 1.93
Operating Cash Flow to Sales Ratio
 0.03 0.16 0.08 0.11 0.13
Free Cash Flow Yield
0.02%4.94%0.34%0.30%6.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 25.59 17.02 26.42 22.83 10.98
Price-to-Sales (P/S) Ratio
 3.63 2.41 3.83 3.29 1.58
Price-to-Book (P/B) Ratio
 3.54 2.35 4.08 3.47 1.68
Price-to-Free Cash Flow (P/FCF) Ratio
 5.36K 20.26 298.02 332.07 15.91
Price-to-Operating Cash Flow Ratio
 142.23 14.77 48.66 31.09 12.32
Price-to-Earnings Growth (PEG) Ratio
 2.59 1.74 1.24 2.87 0.26
Price-to-Fair Value
 3.54 2.35 4.08 3.47 1.68
Enterprise Value Multiple
 15.51 10.71 18.69 13.76 6.69
Enterprise Value
 105.10B 64.65B 98.83B 70.03B 26.65B
EV to EBITDA
 16.22 10.71 18.69 13.76 6.69
EV to Sales
 3.56 2.19 3.77 3.22 1.44
EV to Free Cash Flow
 5.26K 18.42 292.87 324.69 14.50
EV to Operating Cash Flow
 139.79 13.42 47.82 30.40 11.22
Tangible Book Value Per Share
 63.81 63.78 52.44 43.71 39.86
Shareholders’ Equity Per Share
 66.74 66.70 54.45 45.55 42.01
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.24 0.26 0.21
Revenue Per Share
 65.14 65.11 57.89 48.03 44.59
Net Income Per Share
 9.23 9.22 8.40 6.92 6.41
Tax Burden
 0.75 0.75 0.76 0.74 0.79
Interest Burden
 1.02 1.11 1.13 0.97 0.97
Research & Development to Revenue
 0.02 0.00 0.00 0.01 <0.01
SG&A to Revenue
 0.20 0.22 0.11 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.18 1.15 0.54 0.73 0.70
Currency in INR